Global Biopharmaceutical CMO and CRO Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biopharmaceutical CMO and CRO Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Contract Manufacturing
  • 1.4.3 Contract Research
• 1.5 Market by Application
  • 1.5.1 Global Biopharmaceutical CMO and CRO Market Share by Application: 2020 VS 2026
  • 1.5.2 Biologics Manuefacturing
  • 1.5.3 Biosimilars Manuefacturing
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Biopharmaceutical CMO and CRO Market Perspective (2015-2026)
• 2.2 Biopharmaceutical CMO and CRO Growth Trends by Regions
  • 2.2.1 Biopharmaceutical CMO and CRO Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biopharmaceutical CMO and CRO Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biopharmaceutical CMO and CRO Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biopharmaceutical CMO and CRO Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biopharmaceutical CMO and CRO Players by Market Size
  • 3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2015-2020)
  • 3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biopharmaceutical CMO and CRO Market Concentration Ratio
  • 3.2.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2019
• 3.3 Biopharmaceutical CMO and CRO Key Players Head office and Area Served
• 3.4 Key Players Biopharmaceutical CMO and CRO Product Solution and Service
• 3.5 Date of Enter into Biopharmaceutical CMO and CRO Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2015-2020)
• 4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2021-2026)

5 Biopharmaceutical CMO and CRO Breakdown Data by Application (2015-2026)

• 5.1 Global Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)
• 5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 6.2 Biopharmaceutical CMO and CRO Key Players in North America (2019-2020)
• 6.3 North America Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 6.4 North America Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 7.2 Biopharmaceutical CMO and CRO Key Players in Europe (2019-2020)
• 7.3 Europe Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 7.4 Europe Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

8 China

• 8.1 China Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 8.2 Biopharmaceutical CMO and CRO Key Players in China (2019-2020)
• 8.3 China Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 8.4 China Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 9.2 Biopharmaceutical CMO and CRO Key Players in Japan (2019-2020)
• 9.3 Japan Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 9.4 Japan Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 10.2 Biopharmaceutical CMO and CRO Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

11 India

• 11.1 India Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 11.2 Biopharmaceutical CMO and CRO Key Players in India (2019-2020)
• 11.3 India Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 11.4 India Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biopharmaceutical CMO and CRO Market Size (2015-2020)
• 12.2 Biopharmaceutical CMO and CRO Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biopharmaceutical CMO and CRO Market Size by Type (2015-2020)
• 12.4 Central & South America Biopharmaceutical CMO and CRO Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AGC Biologics
  • 13.1.1 AGC Biologics Company Details
  • 13.1.2 AGC Biologics Business Overview and Its Total Revenue
  • 13.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction
  • 13.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2015-2020))
  • 13.1.5 AGC Biologics Recent Development
• 13.2 Boehringer Ingelheim International GmbH
  • 13.2.1 Boehringer Ingelheim International GmbH Company Details
  • 13.2.2 Boehringer Ingelheim International GmbH Business Overview and Its Total Revenue
  • 13.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction
  • 13.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim International GmbH Recent Development
• 13.3 FUJIFILM Diosynth Biotechnologies
  • 13.3.1 FUJIFILM Diosynth Biotechnologies Company Details
  • 13.3.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
  • 13.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction
  • 13.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
• 13.4 Inno Bio Ventures Sdn Bhd
  • 13.4.1 Inno Bio Ventures Sdn Bhd Company Details
  • 13.4.2 Inno Bio Ventures Sdn Bhd Business Overview and Its Total Revenue
  • 13.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction
  • 13.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.4.5 Inno Bio Ventures Sdn Bhd Recent Development
• 13.5 JRS PHARMA
  • 13.5.1 JRS PHARMA Company Details
  • 13.5.2 JRS PHARMA Business Overview and Its Total Revenue
  • 13.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction
  • 13.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.5.5 JRS PHARMA Recent Development
• 13.6 Lonza
  • 13.6.1 Lonza Company Details
  • 13.6.2 Lonza Business Overview and Its Total Revenue
  • 13.6.3 Lonza Biopharmaceutical CMO and CRO Introduction
  • 13.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.6.5 Lonza Recent Development
• 13.7 PRA Health Sciences, Inc.
  • 13.7.1 PRA Health Sciences, Inc. Company Details
  • 13.7.2 PRA Health Sciences, Inc. Business Overview and Its Total Revenue
  • 13.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction
  • 13.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.7.5 PRA Health Sciences, Inc. Recent Development
• 13.8 ProBioGen AG
  • 13.8.1 ProBioGen AG Company Details
  • 13.8.2 ProBioGen AG Business Overview and Its Total Revenue
  • 13.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction
  • 13.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.8.5 ProBioGen AG Recent Development
• 13.9 Rentschler Biopharma SE
  • 13.9.1 Rentschler Biopharma SE Company Details
  • 13.9.2 Rentschler Biopharma SE Business Overview and Its Total Revenue
  • 13.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction
  • 13.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.9.5 Rentschler Biopharma SE Recent Development
• 13.10 Samsung BioLogics
  • 13.10.1 Samsung BioLogics Company Details
  • 13.10.2 Samsung BioLogics Business Overview and Its Total Revenue
  • 13.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction
  • 13.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2015-2020)
  • 13.10.5 Samsung BioLogics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer